Pharma Journalist -

Understanding your audience through digital channels is key in today's healthcare world, as patients are using devices and moving more onto online communications to contact and find…
Read More...

Denali Therapeutics Inc. announced that it will collaborate with Sanofi on the development of multiple RIPK1 inhibitor molecules with the potential to treat a range of neurological and…
Read More...

Pharmaceutical Product Development, LLC (PPD) has enhanced its global product development services, adding significant expertise in multiple therapeutic areas, including neuroscience,…
Read More...

PMI BioPharma Solutions, a specialty CDMO providing Contract Research, Drug Discovery, Development and Manufacturing Services officially formed in January of 2018, announced that David…
Read More...

Gilead Sciences and Tango Therapeutics announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted immuno-oncology treatments for…
Read More...

Novo Nordisk announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights to Macrilen(TM) (macimorelin), the first and only FDA-approved oral…
Read More...

AbbVie announced that the European Commission (EC) has approved the type-II variation application for VENCLYXTO (venetoclax) in combination with rituximab for the treatment of patients…
Read More...

SMi Reports: Registration is now officially open for SMi’s Superbugs & Superdrugs Conference, returning for its 21st year to London, UK on the 18th and 19th March 2019.  As the…
Read More...

Puration confirmed the developing joint venture agreement with Kali, Inc. and Nouveau Life Pharmaceuticals, Inc. to develop cannabis pharmaceutical products. Puration further confirms…
Read More...

As part of CoreRx, Inc's growth in expanding its cGMP manufacturing capabilities to support niche commercial products, we are pleased to announce the completed installation of the Optel…
Read More...